the aid library

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Key
Resources

Clinical
Guidelines

Women & Child
Health

Pharmacy &
Technologies

English

English Deutsch Español Français русский عربى

My MEDBOX Register

Login
Register
English
- English
- Deutsch
- Español
- Français
- русский
- عربى

Search database

Create your MEDBOX

LIST OPTIONS

Filter

Filtered Results: 46

Text search: Kraus J.

Featured

New Publications

Language

English

Russian

Spanish

German

Indonesian

Ukrainian

Document type

Studies & Reports

No document type

Guidelines

Manuals

Strategic & Response Plan

Situation Updates

Fact sheets

Countries / Regions

Western and Central Europe

Russia

Ukraine

Eastern Europe and Central Asia

Eastern Europe

Global

Nigeria

Uganda

India

Germany

Indonesia

Malaysia

South Africa

Argentina

Botswana

Bolivia

Chile

South–East Asia Region

Paraguay

Africa

Japan

Authors & Publishers

European Centre for Disease Prevention and Control ECDC

IACAPAP

World Health Organization WHO, Regional Office of Europe

et al.

Global Heart

World Health Organization WHO

E. van der Sloot

J. J. Hudziak

K. O’Loughlin

R. Vermeiren

A. Vieno

Abida Haq binti Syed M. Haq et al.

Aliku, T. et al.

Amodeo, C. et al.

Barnes, H.

Cerda A. A., Garcia L. Y.

Collins, T.E.

D.Currie

Disability, CBR & Inclusive Development Journal (DCIDJ)

Erwinanto, A. Santoso, J. N. E. Putranto, et al.,

F1000 Research

Federal Ministry of Health, Nigeria

Ferreira, J.P.

Fewer S.

Frontiers in Cardiovascular Medicine

Galarza, P. et al.

Globalization and Health

Goh, N. S. L.

H. Sakamoto

Hartley, S.

HBSC

Hitzeroth, J.

Hoy, R.

Indian Consensus of Medical Research

Indonesian Heart Association

Institut für Public Health und Pflegeforschung, Universität Bremen

International Journal of Health Policy and Management

J. Inchley

Jemoon, P.

Jindal, D.

Klug, E. et al.

Kraus J.

Kraus J. et al.

Kraus, S.

Leong, T. L.

M. K. Sugai et al.

Ministerio de Salud Argentina

Ministerio de salud y deportes, Bolivia

Ministry of Health Malaysia

Minja, N.W.

Mitchell, S. et al.

Mpe, M.

Nakagaayi, D.

Nomura S. et al.

Nomura, S.

Nugent, R.

Official Journal of the Asian Pacific Society of Respirology

R. R. Althoff

Redfern, J. et al.

Schäferhoff M.

Schäferhoff M. et al.

Seitio-Kgokgwe, Gauld, Hill et al

Séverin, T.

Szenenwechsel

The British Medical Journal (BMJ)

The Lancet

The South African Medical Journal

Torales, G.

Tromp, J.

UNICEF

unicef, Український інститут соціальних досліджень імені Олександра Яременка,Дизайн, верстка, друк – ТОВ ВПК «ОБНОВА»

United Nations Office on Drug and Crime UNODC

Webb, D.

WHO Europe

World Bank

World Health Organization

World Health Organization (Europe)

World Health Organization (WHO)

World Health Organization (WHO), Regional Office for South-East-Asia

Yamey G.

Всемирная организация здравоохранения. Европейское региональное бюро

О.М. Балакірєва,Т.В. Бондар, Я.О. Сазонова et al.

Publication Years

2000-2009

2010-2019

2020-2025

Hesitation and Refusal Factors in Individuals' Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination

Cerda A. A., Garcia L. Y. (2021) C2

Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...tion will be needed to support a potential campaign to promote vaccination. Objective: The aim of this study was to determine the variables affecting the likelihood of refusal and indecision toward a vaccine against COVID-19 and to determine the acceptance of the vaccine for different scenarios of effectiveness and side effects. Materials and Methods: A multinomial logistic regression method based on the Health Belief Model was used to estimate the current methodology, using data obtained by an online anonymous survey of 370 respondents in Chile. Results: The results indicate that 49% of respondents were willing to be vaccinated, with 28% undecided or 77% of individuals who would potentially be willing to be inoculated. The main variables that explained the probability of rejection or indecision were associated with the severity of COVID-19, such as, the side effects and effectiveness of the vaccine; perceived benefits, including immunity, decreased fear of contagion, and the protection of oneself and the environment; action signals, such as, responses from ones' family and the government, available information, and specialists' recommendations; and susceptibility, including the contagion rate per 1,000 inhabitants and relatives with COVID-19, among others. Our analysis of hypothetical vaccine scenarios revealed that individuals preferred less risky vaccines in terms of fewer side effects, rather than effectiveness. Additionally, the variables that explained the indecision toward or rejection of a potential COVID-19 vaccine could be used in designing public health policies. Conclusions: We discovered that it is necessary to formulate specific, differentiated vaccination-promotion strategies for the anti-vaccine and undecided groups based on the factors that explain the probability of individuals refusing or expressing hesitation toward vaccination. more

Add to my MEDBOX

Methods for the detection and characterisation of SARS-CoV-2 variants: second update, 21 June 2022

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...including genomic sequencing, or are involved in making decisions on establishing or scaling up capability and capacity to detect and characterize circulating SARS-CoV-2 variants. more

Add to my MEDBOX

Manejo de las reacciones adversas por tratamiento etiologico de la enfermedad de chagas

Ministerio de salud y deportes, Bolivia (2007) C2

El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...iagnóstico serológico positivo confirmado y el nifurtimox (NFT) que será utilizado como segunda alternativa en aquellos casos que hubieran presentado reacciones adversas graves al benznidazol, e indiquen un cambio de conducta. more

Add to my MEDBOX

Analysis of Pandemic Preparedness and Response (PPR) architecture, financing needs, gaps and mechanisms

World Bank (2022) CC

A global Pandemic, Preparedness and Response (RRR) architecture

Add to my MEDBOX

Global technical consultation report on proposed terminology for pathogens that transmit through the air

World Health Organization WHO (2024) C_WHO

Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...nd ‘aerosol transmission’ were used in different ways by stakeholders in different scientific disciplines, which may have contributed to misleading information and confusion about how pathogens are transmitted in human populations. This global technical consultation report brings together viewpoints from experts spanning a range of disciplines with the key objective of seeking consensus regarding the terminology used to describe the transmission of pathogens through the air that can potentially cause infection in humans. This consultation aimed to identify terminology that could be understood and accepted by different technical disciplines. The agreed process was to develop a consensus document that could be endorsed by global agencies and entities. Despite the complex discussions and challenges, significant progress was made during the consultation process, particularly the consensus on a set of descriptors to describe how pathogens are transmitted through the air and the related modes of transmission. WHO recognizes the important areas where consensus was not achieved and will continue to address these areas in follow-up consultations. more

Add to my MEDBOX

Silica-associated lung disease: An old-world exposure in modern industries

Barnes, H.; Goh, N. S. L.; Leong, T. L.; Hoy, R. Official Journal of the Asian Pacific Society of Respirology (2019) CC2

Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... the introduction of mechanized tools in the mining sector rapidly increased levels of silica exposure, resulting in an increase in cases and our understanding of silicosis. more

Create your own MEDBOX
Login

Home
Contact
Data privacy
Legal notice
FAQ
About
Sitemap

A Project by

dev-medbox @ 2025